Cytovance Biologics Promotes John Mott to Vice President of Development
July 13, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 13, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the promotion of Dr. John...
Cytovance Biologics Announces Yuk Chun Chiu as Vice President of Manufacturing Operations
July 06, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces Yuk Chun Chiu as Vice...
Open Book Extracts Acquires Chilmark Labs to Commercialize Rare Cannabinoids and Pioneer Scientific Research and Technologies for the CBD Industry
June 15, 2020 07:00 ET
|
Open Book Extracts
ROXBORO, N.C., June 15, 2020 (GLOBE NEWSWIRE) -- Open Book Extracts, one of the leading vertically integrated, cGMP certified processors of high-quality cannabinoid products, is pleased to announce...
Open Book Extracts Receives “Excellent” Audit Rating in Current Good Manufacturing Practices (cGMP) Certification
April 27, 2020 07:00 ET
|
Open Book Extracts
ROXBORO, N.C., April 27, 2020 (GLOBE NEWSWIRE) -- In a time where health and safety has never been more important, Open Book Extracts (OBX) is pleased to announce its designation as a certified...
Cytovance Biologics Promotes Dr. Jesse McCool to Chief Executive Officer
March 30, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of Dr. Jesse...
Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hemp and Minor Cannabinoid Processing Industry
December 05, 2019 08:45 ET
|
Akers Biosciences Inc.
· Establishes Advisory Board appointing Bob Hoban and Michael Patterson Thorofare, New Jersey, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ:...
Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture
October 21, 2019 12:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics is a leading biopharmaceutical CDMO with a 15-year track record of supplying drug substance to clients, offering fast and...
Translate Bio Announces Strategic Manufacturing Agreement with AMRI in Support of Messenger RNA (mRNA) Manufacturing
September 12, 2019 16:05 ET
|
Translate Bio, Inc.
-- Agreement provides Translate Bio with customized and dedicated manufacturing space for cGMP mRNA production for current and future programs -- LEXINGTON, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE)...
Sorrento Provides Updates on CD38 Immunotherapies and Implementation of Disruptive GMP Manufacturing for “Off-The-Shelf” Cell Therapy
June 19, 2019 07:00 ET
|
Sorrento Therapeutics, Inc.
“CD38 Therapeutics” Business Unit formed to focus on development of CD38-directed immunotherapies for potential out-licensing, collaboration and/or other strategic considerations○ Clinical...
Sorrento Establishes Business Unit to Address Market Opportunity for Proprietary Water Soluble Cannabidiol (CBD) Formulations
April 16, 2019 09:00 ET
|
Sorrento Therapeutics, Inc.
Cannabidiol (CBD) material from virtually THC-free (<0.3%) hemp plants sourcesExcipients on the FDA approved GRAS (Generally Regarded As Safe) listWater soluble formulations with target...